The mammary epithelium is highly responsive to hormonal and non-hormonal signalling cues for physiological growth, function and tissue remodelling. Whilst steroid hormones freely diffuse across the cell membrane to bind to intracellular hormone receptors, cell-impermeable ligands, including many peptide hormones, growth factors and cytokines, bind to receptors on the plasma membrane and relay their message via the specific activation of intracellular signal transduction pathways. A signalling pathway that is indispensable for decoding many extracellular signals into cellular responses is calcium (Ca 2+ ). Changes in the expression of specific Ca 2+ channels, pumps and binding proteins may therefore greatly alter the nature of the cellular response to various growth, morphogenetic and cell death stimuli. This review summarises changes in the expression, localisation and function of key Ca 2+ channels and pumps in mammary epithelial cells during lactation and discusses how this altered Ca 2+ handling may later expose these cells to targeted cell death during post-lactational involution. A greater understanding of the processes regulating the growth, death and regeneration of the mammary epithelium under physiological conditions may provide important insights into the proliferation and survival mechanisms underpinning malignant growth. The therapeutic manipulation of specific calcium signalling pathways in breast cancer cells to control aberrant cell proliferation and/or turnover represents an aim for the future.
Introduction
The adult mammary gland is composed of a bifurcating and bilayered ductal tree embedded within an adipocyte-rich stroma. Two distinct epithelial cell types are present in the mammary gland: luminal epithelial cells line the lumen of each duct and are surrounded by a layer of basal (myoepithelial) cells in contact with the basement membrane [1, 2] . After puberty, these cells remain largely quiescent, with some proliferation producing small alveolar buds in response to cyclical ovarian stimulation [3] . However, during pregnancy mammary epithelial cells rapidly proliferate to form lobuloalveolar structures that are able to produce and expel milk for neonatal nourishment. Once lactation is complete, the mammary gland regresses to a nulliparous-like state, capable of sustaining further cycles of growth, secretion and cell death with subsequent pregnancies [1, 4] . The complete elimination of the alveolar epithelium during post-lactational involution is a major cell death event in mammals [5] , and it is not yet understood how ductal epithe-lial cells and putative alveolar stem cells evade this cell death programme. The remarkable capacity of the mammary epithelium to reinstate a proliferative programme and to selectively regulate cell death under physiological conditions may provide important insights into the proliferation and survival mechanisms that support malignant growth.
Post-lactational involution of the mammary gland occurs in two distinct phases: an early, reversible phase and a late, remodelling phase [5, 6] . The first phase of involution is characterised by milk stasis and the STAT3-dependent conversion of luminal alveolar cells from a secretory to a phagocytic phenotype [7, 8] . The reuptake of milk fat globules (MFGs) and their delivery to and degradation by lysosomes results in lysosomal membrane permeabilisation and the subsequent leakage of cathepsin proteases into the cytosol [7] . In addition to the release of these executioner proteases, lysosomal membrane permeabilisation in phagocytic mammary epithelial cells could also dramatically elevate cytosolic Ca 2+ levels. Resting cytosolic Ca 2+ concentrations are tightly regulated at submicromolar levels [9] . By comparison, milk contains approximately 8 mM and 60 mM Ca 2+ in humans and mice, respectively [10] . Thus, the reabsorption of secreted milk and the uncontrolled release of milk Ca 2+ into the cytoplasm of luminal epithelial cells may deliver a secondary cell death signal (Fig. 1) . Moreover, Ca 2+ may also play a key role in the signalling events that instigate the switch from lactation to involution. This review discusses key basolateral and apical pathways involved in the fortification of milk with Ca 2+ during lactation and investigates how this Ca 2+ signalling toolkit may later expose these cells to programmed cell death, providing a basis for the targeted removal of the alveolar epithelium during mammary gland involution.
Basolateral Ca 2+ entry
The dramatic expansion of the mammary epithelium during pregnancy is accompanied by marked angiogenic growth, such that by parturition networks of capillaries envelope each alveolus, providing luminal cells with an ample source of Ca 2+ and other nutrients for milk production ( Fig. 2) [11] . Until recently, the identity of the Ca 2+ channels responsible for Ca 2+ entry across the basolateral (blood-facing) membrane of luminal secretory cells during lactation was not known [12] [13] [14] [15] . In 2011, McAndrew et al. demonstrated that the then newly-identified store-operated Ca 2+ channel pore-forming subunit Orai1 was significantly up-regulated in mammary tissue of lactating mice, and postulated that this Ca 2+ influx channel was responsible for the passage of Ca 2+ ions into luminal epithelial cells during lactation [13] . This study also revealed that ORAI1 mRNA levels were elevated in human breast cancer cell lines, indicating that ORAI1-mediated Ca 2+ influx not only regulates processes important for the physiological function of mammary epithelial cells, but that these channels may also drive malignant cell behaviours. This work provided the impetus for in vivo milking studies using transgenic mice with targeted disruption of Orai1. These analyses confirmed that ORAI1 is critically important for milk Ca 2+ enrichment, transporting more than half of milk Ca 2+ across the basolateral membrane (Fig. 1a) [15] . These studies also revealed an essential role for ORAI1 in oxytocinmediated contractility of basal epithelial cells, a process essential for milk ejection [15] .
An important question is whether ORAI1 is principally activated in a store-dependent or independent manner in luminal epithelial cells during lactation. Store-operated Ca 2+ entry through ORAI channels is activated in response to endoplasmic reticulum (ER) Ca 2+ store depletion. This may occur, for example, by receptor-mediated activation of phospholipase C (PLC) [16] . PLC hydrolyses the membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP 2 ), producing inositol 1,4,5-trisphosphate (IP 3 ), which binds to and activates IP 3 receptor Ca 2+ channels on the ER; depleted ER Ca 2+ levels are then detected by the ER Ca 2+ sensor STIM1, which activates Ca 2+ influx through plasma membrane ORAI channels [17] [18] [19] [20] [21] [22] . However, ORAI1 can also be activated independently of STIM1 and the filling state of intracellular Ca 2+ stores. Alternative mechanisms for ORAI1 channel opening include activation by STIM2 [23] and the Golgi Ca 2+ pump secretory pathway Ca 2+ ATPase (SPCA) 2 [24] , as well as by arachadonic acid (ORAI1/3 heteromultimers) [25] . Indeed, non-stimulated Ca 2+ influx has been observed in 2D and 3D mammary culture models, with evidence in support of both SPCA2- [14] and STIM2- [26] dependent modes of activation reported. A definitive demonstration of the mechanisms underpinning ORAI1 activation in luminal epithelial cells during lactation awaits milking studies using SPCA2, STIM2 and STIM1 mammary-specific knockout mice.
Another important question is whether ORAI1-mediated Ca 2+ signals participate in the involution switch. The transition from lactation to involution is initiated by the cessation of suckling; however, the molecular trigger for this phenotypic conversion has not been conclusively identified [5] . Leukaemia inhibitory factor (LIF) [27, 28] , transforming growth factor ␤-3 (TGF␤-3) [29] and serotonin have all been proposed as potential candidates [30] . LIF and serotonin receptors are known to activate PLC [31, 32] , and are thus likely to signal through store-operated Ca 2+ entry in luminal cells during involution. It is therefore tempting to speculate that ORAI1 channels are up-regulated on the basolateral membrane during lactation to facilitate constitutive, store-independent Ca 2+ entry for milk Ca 2+ enrichment, and that these channels later enhance and/or spatially-regulate store-operated Ca 2+ entry responses to involution cues (Fig. 1b) . Thus, Ca 2+ influx may participate in the coordinated activation of intracellular signal transduction pathways important for initiating targeted cell death in the mammary gland. Indeed, signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa B (NFKB), two key involution signalling proteins, have previously been shown to be highly regulated by calcium signalling microdomains in breast cancer cells and neuronal cultures, respectively [33, 34] . Further studies are required to determine whether these proteins are also regulated by spatially-restricted calcium signals in mammary epithelial cells during involution.
Deciphering the precise in vivo role of ORAI1 and its activators in milk Ca 2+ enrichment and involution signalling necessitates their specific genetic manipulation in luminal epithelial cells, e.g., using BLG-Cre [35] or WAP-Cre [36] mouse models to direct Crerecombinase expression to the luminal cell lineage for targeted gene disruption. The complex roles for ORAI1 channels in the mammary gland cannot currently be unravelled using pharmacological approaches, given that ORAI1-mediated Ca 2+ entry is also essential for milk ejection by mammary myoepithelial cells [15] . Nevertheless, important information regarding the roles of these channels and their activators during involution can be garnered by the genetic and pharmacological modulation of ORAI1 channel function in luminal cell culture models.
The therapeutic targeting of ORAI1 channels is an area of intense investigation. Many of the pharmacological agents that have traditionally been used to block store-operated Ca 2+ entry in cell culture and/or rodent models, e.g., the lanthanides (Gd 3+ and La 3+ ) and 2-aminoethyldiphenyl borinate (2-APB), do so non-specifically [37] . For example, lanthanides inhibit store-operated Ca 2+ entry channels in the sub-micromolar range, but also inhibit voltagegated Ca 2+ channels (>1 M), transient receptor potential canonical (TRPC) channels (∼100 M) and Ca 2+ ATPases (>1 mM). The pharmacological utility of the lanthanides is also limited by their poor solubility in media containing serum or phosphate buffers [37] . The pharmacology of 2-APB in blocking store-operated Ca 2+ entry is also highly complex, with differential modes of inhibition and activation, dependent on the concentration of 2-APB and the channel isoform expressed [37] [38] [39] [40] [41] . More recently, new inhibitors of ORAI1 calcium channels have been described, e.g., AMG-1 (Amgen), and have been successfully used to target T-cell mediated autoimmune diseases in mice [42] . Further work is required to determine the role of ORAI1 Ca 2+ channels in the targeted cell death of the alveolar epithelium during involution, and whether the elevated expression of this channel in certain breast cancers [13, 43] could be exploited in a similar manner for the treatment of breast cancer.
Apical Ca 2+ efflux
Plasma membrane Ca 2+ ATPases (PMCAs) are a family of Ptype Ca 2+ pumps that extrude Ca 2+ from the cytosol and play an integral role in epithelial Ca 2+ homeostasis and signalling [44] . Four PMCA isoforms are expressed in mammals (PMCA1-4). These pumps are characterised by a long C-terminal tail, comprising a calmodulin (CaM)-binding domain [44, 45] . In the absence of CaM, the CaM-binding domain binds to and self-inhibits pump activity [44] . Whilst PMCA4 and PMCA1 are ubiquitously expressed, the latter being essential for life [46] , PMCA2 and PMCA3 have a more restricted tissue distribution. PMCA2 is dramatically upregulated in the mammary epithelium during pregnancy and lactation [47] [48] [49] , where it is constantly shed into the milk via secretory exocytosis and replenished with newly synthesised protein [12, 48] . This Ca 2+ pump displays fast Ca 2+ stimulation kinetics and is highly active in the absence of calmodulin, enabling the rapid and persistent efflux of Ca 2+ across the apical membrane of mammary epithelial cells during lactation [45, 50, 51] . Indeed, in vivo milking studies in Pmca2 null mice have revealed that this Ca 2+ ATPase is responsible for 60-70% of milk Ca 2+ transport across the apical membrane (Fig. 1a) [49, 51] .
PMCA2 expression is rapidly downregulated during involution (Fig. 1b) [49, 52, 53] . Elegant experiments to induce milk stasis and involution in mice by teat sealing have revealed significant reductions in PMCA2 protein levels as early as four hours post-sealing [52] . Importantly, no changes in PMCA2 expression were observed in the contralateral (unsealed) mammary glands, suggesting that the mechanism by which PMCA2 is downregulated during involution is governed by local factors. PMCA2 levels continue to decline during the early phase of involution and are barely detectable after 24 h. The sudden and dramatic loss of this major Ca 2+ extru-sion pathway in mammary epithelial cells is likely to result in an increase in their basal cytosolic Ca 2+ concentration [53, 54] .
An increase in cytosolic Ca 2+ levels in luminal epithelial cells during involution is thought to activate cytosolic calpains (CAPNs) [52, 54] . A role for CAPNs in post-lactational involution has been demonstrated pharmacologically in mice that were administered the cell-permeable CAPN inhibitor calpeptin during involution [54] . CAPN1 and −2 are cysteine proteases that are activated by micromolar and millimolar Ca 2+ concentrations, respectively. Capn1 and -2 mRNA levels are increased within 24 h of involution, and CAPN protease activity is increased by 24-48 h [52, 54] . CAPN activity is also increased within the lysosomal compartment during involution, where it has been suggested to contribute to lysosomal destabilisation [54] . The re-uptake of milk during mammary involution and the CAPN-and/or MFG-dependent release of milk Ca 2+ from lysosomes may further augment cytosolic CAPN activity, reinforcing this cell death cascade. In this context, it is important to note that calpeptin also inhibits the lysosomal protease cathepsin L [55] , which is expressed early in involution and is also suspected to play an important role in this process [8] . Thus, further studies in this area are required to delineate these pathways in post-lactational involution and their calcium dependence.
In addition to its role in regulating physiological cell death in the mammary gland, PMCA2 has been proposed as a therapeutic target in breast cancer [52, [56] [57] [58] [59] [60] . Overexpression of PMCA2 in T47D breast cancer cells protects against Ca 2+ -induced CAPN activation and cell death [52] . Additionally, PMCA2 has been shown to regulate HER2 localisation and signalling in HER2 positive breast cancer cells [56] . Whilst various pan-PMCA inhibitors have been used to experimentally block PMCA activity, e.g., La 3+ , orthovanadate and carboxyeosin, these compounds display off-target effects and are not isoform-selective. A significant challenge in the development of PMCA inhibitors arises from the limited access to these pumps from the outside of the cell, with the majority of their protein mass located intracellularly [61] . Nevertheless, with improved structural information and the emergence of new avenues for biological therapies, the selective targeting of PMCAs may one day offer a pathway forward in the treatment of breast cancer.
Conclusion
Most women will experience one or more pregnancies in their lifetime. This extraordinary biological event is associated with the recruitment of mammary alveolar stem/progenitor cells; invasive growth and remodelling of the mammary epithelium; marked angiogenesis; and ultimately coordinated cell death of the alveolar epithelium. However, our understanding of the fundamental processes regulating the growth, death and regeneration of this organ are incomplete, despite its parallels to breast cancer. This review discussed the calcium ion as essential cargo for secretory cells during lactation, and subsequently outlined mechanisms by which the expression signature of Ca 2+ channels and pumps in the alveolar epithelium during lactation may specifically expose these cells to programmed cell death during post-lactational involution. The pharmaceutical mimicry of Ca 2+ -mediated cell death in breast cancer cells, which exhibit remarkably similar changes in Ca 2+ signalling proteins, may represent a new era in the therapeutic targeting of this pervasive disease.
